"This is the kind of analysis now possible because electronic medical records are widely available," said the lead author, Nigam H. Shah, an assistant professor of medicine at Stanford. "It's a benefit of the electronic records system that people are always talking about."
"是电子病历的广泛使用才使得这样的分析成为可能,"该研究的主要作者,斯坦福大学(Stanford)的医学助理教授尼加姆·H·沙阿(Nigam H. Shah)说。"这是电子病历系统为人津津乐道的优点之一。"
There was no association of heart attack with another class of drugs used to treat gastric reflux, H2 blockers like Zantac, Tagamet and Pepcid. The researchers suggest that P.P.I.'s promote inflammation and clots by interfering with the actions of protective enzymes.
治疗胃反流的另一类药物——H2受体拮抗剂/阻滞剂(如甲胺呋硫、泰胃美和法莫替丁等)则与心机梗死无相关性。研究人员认为,P.P.I.会促进炎症和血栓是因为它可干扰保护酶的活动。
A significant limitation of the study, in PLOS One, is that P.P.I. usage may be a marker of a sicker patient population, more subject to heart disease in any case.
不过,这项发表在《公共科学图书馆:综合》杂志上的研究也存在着显著的局限性:使用P.P.I.可能是病情较重的患者人群的一个标志,这些人本来就更容易患心脏病。
【某些胃药可能增加心肌梗死的风险】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15